• Developed a novel small-molecule aCDase inhibitor, compound 5A, demonstrated efficacy in enhancing ECM degradation and resolving fibrosis in two mouse models.
• Developed a novel small-molecule aCDase inhibitor, compound 5A, demonstrated efficacy in enhancing ECM degradation and resolving fibrosis in two mouse models.
• Stimulate HSCs to degrade the extracellular matrix (ECM) and promote fibrosis resolution.
• Uncover a key signaling mechanism, protein kinase Cα (PKCα) regulated AP1-MMP1 axis, which induces ECM breakdown.
• Stimulate HSCs to degrade the extracellular matrix (ECM) and promote fibrosis resolution.
• Uncover a key signaling mechanism, protein kinase Cα (PKCα) regulated AP1-MMP1 axis, which induces ECM breakdown.